Professor Emeritus David L. Sackett, Developer of Evidence Based Medicine
By HospiMedica International staff writers Posted on 01 Jun 2015 |
Image: Professor Emeritus David Lawrence Sackett, MD (Photo courtesy of McMaster University).
Professor Emeritus David Lawrence Sackett, MD, widely regarded as the father of evidence based medicine (EBM), died on May 13, 2015, in Canada.
Prof. Sackett obtained his medical degree at the University of Illinois (Champaign, USA) and was drafted into the US Public Health Service in 1962 as a result of the Cuban missile crisis. He received a master’s degree in epidemiology from Harvard University (Boston, MA, USA), and became interested in how the methods of epidemiology could be applied to clinical medicine, calling the combination clinical epidemiology. In 1968, the 32 year old Sackett founded Canada’s first department of clinical epidemiology and biostatistics at McMaster University (Hamilton, ON, Canada), coining the term EBM.
He remained at McMaster University until 1994, when he left to found the international Center for Evidence-Based Medicine at the University of Oxford (United Kingdom). He officially retired from academia and clinical practice in 1999, and returned to Canada to establish the Trout Research & Education Centre at McMaster. During his career, he was instrumental in developing EBM, a medical approach based on scientific evidence and critical appraisal rather than conventional wisdom.
He developed and mentored a new breed of applied clinician-scientists, and worked with them to create and disseminate EBM throughout the world. His collaborative research teams were the first to validate the efficacy of aspirin and carotid endarterectomy for patients with threatened stroke, to develop effective strategies for helping hypertensive patients, and to generate compelling evidence of the effectiveness of nurse practitioners. He published 10 books, about 50 book chapters, and over 400 papers in medical and scientific journals.
“David Sackett was a true transformer of health care. He questioned established beliefs, and explored emerging areas,” said Holger Schünemann, chair of the department of epidemiology and biostatistics at the McMaster School of Medicine. “His legacy is carried forward through his influential role on clinical trials, systematic reviews, evidence-based medicine and health education worldwide.”
Related Links:
University of Illinois
McMaster University
University of Oxford
Prof. Sackett obtained his medical degree at the University of Illinois (Champaign, USA) and was drafted into the US Public Health Service in 1962 as a result of the Cuban missile crisis. He received a master’s degree in epidemiology from Harvard University (Boston, MA, USA), and became interested in how the methods of epidemiology could be applied to clinical medicine, calling the combination clinical epidemiology. In 1968, the 32 year old Sackett founded Canada’s first department of clinical epidemiology and biostatistics at McMaster University (Hamilton, ON, Canada), coining the term EBM.
He remained at McMaster University until 1994, when he left to found the international Center for Evidence-Based Medicine at the University of Oxford (United Kingdom). He officially retired from academia and clinical practice in 1999, and returned to Canada to establish the Trout Research & Education Centre at McMaster. During his career, he was instrumental in developing EBM, a medical approach based on scientific evidence and critical appraisal rather than conventional wisdom.
He developed and mentored a new breed of applied clinician-scientists, and worked with them to create and disseminate EBM throughout the world. His collaborative research teams were the first to validate the efficacy of aspirin and carotid endarterectomy for patients with threatened stroke, to develop effective strategies for helping hypertensive patients, and to generate compelling evidence of the effectiveness of nurse practitioners. He published 10 books, about 50 book chapters, and over 400 papers in medical and scientific journals.
“David Sackett was a true transformer of health care. He questioned established beliefs, and explored emerging areas,” said Holger Schünemann, chair of the department of epidemiology and biostatistics at the McMaster School of Medicine. “His legacy is carried forward through his influential role on clinical trials, systematic reviews, evidence-based medicine and health education worldwide.”
Related Links:
University of Illinois
McMaster University
University of Oxford
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure